BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 11605132)

  • 1. [The analysis of the cost structures of the treatment of schizophrenia by means of standardized assessment instruments].
    Kilian R; Roick C; Matschinger H; Bernert S; Mory C; Angermeyer MC
    Psychiatr Prax; 2001 Oct; 28 Suppl 2():S102-8. PubMed ID: 11605132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment.
    Kilian R; Matschinger H; Löeffler W; Roick C; Angermeyer MC
    J Ment Health Policy Econ; 2002 Mar; 5(1):21-31. PubMed ID: 12529567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Instruments for the economical evaluation of psychiatric service systems: methodological foundations of the European standardisation and the German adaptation].
    Kilian R; Roick C; Bernert S; Matschinger H; Mory C; Becker T; Angermeyer MC
    Psychiatr Prax; 2001 Oct; 28 Suppl 2():S74-8. PubMed ID: 11605127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Longitudinal analysis of factors influencing direct costs of schizophrenia treatment].
    Kilian R; Matschinger H; Angermeyer MC
    Gesundheitswesen; 2003 Mar; 65(3):173-80. PubMed ID: 12698387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The regional psychiatry budget (RPB): a model for a new payment system of hospital based mental health care services].
    König HH; Heinrich S; Heider D; Deister A; Zeichner D; Birker T; Hierholzer C; Angermeyer MC; Roick C
    Psychiatr Prax; 2010 Jan; 37(1):34-42. PubMed ID: 20072988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The impact of antipsychotic medication on the incidence and the costs of inpatient treatment in people with schizophrenia: results from a prospective observational study].
    Kilian R; Angermeyer MC
    Psychiatr Prax; 2004 Apr; 31(3):138-46. PubMed ID: 15042477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The functionality and economic costs of outpatients with schizophrenia in Taiwan.
    Lee IH; Chen PS; Yang YK; Liao YC; Lee YD; Yeh TL; Yeh LL; Cheng SH; Chu CL
    Psychiatry Res; 2008 Apr; 158(3):306-15. PubMed ID: 18243334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The standardized assessment of the need for treatment and support in severe mental illness: the development and testing of the German version of the Camberwell assessment of Need-EU].
    Kilian R; Bernert S; Matschinger H; Mory C; Roick C; Angermeyer MC
    Psychiatr Prax; 2001 Oct; 28 Suppl 2():S79-83. PubMed ID: 11605128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient antipsychotic treatment and inpatient costs of schizophrenia.
    Marcus SC; Olfson M
    Schizophr Bull; 2008 Jan; 34(1):173-80. PubMed ID: 17578893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Distribution of costs in schizophrenia treatment--approaches to management and integration].
    Schleuning G; Heel S
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S6-8. PubMed ID: 15570485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The societal cost of schizophrenia in Sweden.
    Ekman M; Granstrom O; Omerov S; Jacob J; Landen M
    J Ment Health Policy Econ; 2013 Mar; 16(1):13-25. PubMed ID: 23676412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health care resource use associated with integrated psychological treatment.
    Vasiliadis HM; Briand C; Lesage A; Reinharz D; Stip E; Nicole L; Lalonde P
    J Ment Health Policy Econ; 2006 Dec; 9(4):201-7. PubMed ID: 17200597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost of care of schizophrenia: a study of Indian out-patient attenders.
    Grover S; Avasthi A; Chakrabarti S; Bhansali A; Kulhara P
    Acta Psychiatr Scand; 2005 Jul; 112(1):54-63. PubMed ID: 15952946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The German adaptation of the Verona Service Satisfaction Scale: an instrument for patients' satisfaction with mental health care].
    Mory C; Matschinger H; Roick C; Kilian R; Bernert S; Angermeyer MC
    Psychiatr Prax; 2001 Oct; 28 Suppl 2():S91-6. PubMed ID: 11605130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Direct health-related costs of severely mentally ill patients and their informal carers in community care].
    Kallert TW; Nitsche I
    Neuropsychiatr; 2010; 24(1):42-55. PubMed ID: 20146919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost analysis of treating schizophrenia with amisulpride: naturalistic mirror image study.
    Surguladze S; Patel A; Kerwin RW; Knapp M; Travis MJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):517-22. PubMed ID: 15866352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Caregiver burden in relatives of persons with schizophrenia: an overview of measure instruments].
    Reine G; Lancon C; Simeoni MC; Duplan S; Auquier P
    Encephale; 2003; 29(2):137-47. PubMed ID: 14567165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
    Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
    J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs and benefits of hospital and day treatment with community care of affective and schizophrenic disorders.
    Wiersma D; Kluiter H; Nienhuis FJ; Rüphan M; Giel R
    Br J Psychiatry Suppl; 1995 Apr; (27):52-9. PubMed ID: 7794594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Direct and indirect costs of schizophrenia].
    Kissling W; Höffler J; Seemann U; Müller P; Rüther E; Trenckmann U; Uber A; Graf von der Schulenburg JM; Glaser P; Glaser T; Mast O; Schmidt D
    Fortschr Neurol Psychiatr; 1999 Jan; 67(1):29-36. PubMed ID: 10065387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.